Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Colorectal Neoplasms

  Free Subscription


10.12.2018

1 Am J Surg
1 Ann Oncol
2 Anticancer Res
5 BMC Cancer
1 Eur J Gastroenterol Hepatol
2 Gastroenterology
4 Int J Cancer
1 Int J Colorectal Dis
1 Lancet Gastroenterol Hepatol
1 Lancet Oncol
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg

  1. OSAGIEDE O, Spaulding AC, Cochuyt JJ, Naessens JM, et al
    Disparities in minimally invasive surgery for colorectal cancer in Florida.
    Am J Surg. 2018 Nov 27. pii: S0002-9610(18)31299.
    PubMed     Text format     Abstract available


    Ann Oncol

  2. SHITARA K, Yamanaka T, Denda T, Tsuji Y, et al
    REVERCE: A Randomized Phase II Study of Regorafenib Followed by Cetuximab Versus the Reverse Sequence for Previously Treated Metastatic Colorectal Cancer Patients.
    Ann Oncol. 2018 Dec 3. pii: 5227619. doi: 10.1093.
    PubMed     Text format     Abstract available


    Anticancer Res

  3. SHIBUYA N, Ishizuka M, Takagi K, Iwasaki Y, et al
    Relationship Between Preoperative Erythrocyte Sedimentation Rate and Survival After Surgery in Patients with Colorectal Cancer.
    Anticancer Res. 2018;38:6783-6788.
    PubMed     Text format     Abstract available

  4. MATSUTANI S, Shibutani M, Maeda K, Nagahara H, et al
    Tumor-infiltrating Immune Cells in H&E-stained Sections of Colorectal Cancer Tissue as a Reasonable Immunological Biomarker.
    Anticancer Res. 2018;38:6721-6727.
    PubMed     Text format     Abstract available


    BMC Cancer

  5. FORTEA-SANCHIS C, Martinez-Ramos D, Escrig-Sos J
    The lymph node status as a prognostic factor in colon cancer: comparative population study of classifications using the logarithm of the ratio between metastatic and nonmetastatic nodes (LODDS) versus the pN-TNM classification and ganglion ratio syste
    BMC Cancer. 2018;18:1208.
    PubMed     Text format     Abstract available

  6. DIMITRIOU N, Felekouras E, Karavokyros I, Alexandrou A, et al
    Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
    BMC Cancer. 2018;18:1202.
    PubMed     Text format     Abstract available

  7. OYEYEMI SO, Braaten T, Licaj I, Lund E, et al
    Physical activity patterns and the risk of colorectal cancer in the Norwegian Women and Cancer study: a population-based prospective study.
    BMC Cancer. 2018;18:1216.
    PubMed     Text format     Abstract available

  8. DEN BAKKER CM, Schaafsma FG, Huirne JAF, Consten ECJ, et al
    Cancer survivors' needs during various treatment phases after multimodal treatment for colon cancer - is there a role for eHealth?
    BMC Cancer. 2018;18:1207.
    PubMed     Text format     Abstract available

  9. PETRERA M, Paleari L, Clavarezza M, Puntoni M, et al
    The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 x 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients.
    BMC Cancer. 2018;18:1210.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  10. DE KLERK CM, Woudstra AJ, Fransen MP, Bossuyt PM, et al
    Invitees do not adequately act on alarm symptoms in colorectal cancer screening with fecal immunochemical tests.
    Eur J Gastroenterol Hepatol. 2019;31:141-142.
    PubMed     Text format    


    Gastroenterology

  11. MURPHY CC, Wallace K, Sandler RS, Baron JA, et al
    Racial Disparities in Incidence of Young-onset Colorectal Cancer and Patient Survival.
    Gastroenterology. 2018 Dec 3. pii: S0016-5085(18)35370.
    PubMed     Text format     Abstract available

  12. TAU A, Bernica J, Thrift AP, El-Serag HB, et al
    Temporal Trends in (Screen/ Non-adherence/Interval) Detected Colorectal Cancer. A Possible Healthcare System Quality Measure.
    Gastroenterology. 2018 Oct 25. pii: S0016-5085(18)35192.
    PubMed     Text format    


    Int J Cancer

  13. IBRAHIM A, Hugerth L, Hases L, Saxena A, et al
    Colitis-induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity.
    Int J Cancer. 2018 Dec 4. doi: 10.1002/ijc.32037.
    PubMed     Text format     Abstract available

  14. JIANG W, Cai M, Li S, Bei J, et al
    Universal screening for Lynch Syndrome in a large consecutive cohort of Chinese colorectal cancer patients: high prevalence and unique molecular features.
    Int J Cancer. 2018 Dec 6. doi: 10.1002/ijc.32044.
    PubMed     Text format     Abstract available

  15. ROSEWEIR AK, Clark J, McSorley ST, van Wyk HC, et al
    The association between markers of tumor cell metabolism, the tumor microenvironment and outcomes in patients with colorectal cancer.
    Int J Cancer. 2018 Dec 6. doi: 10.1002/ijc.32045.
    PubMed     Text format     Abstract available

  16. PETIMAR J, Tabung FK, Valeri L, Rosner B, et al
    Mediation of Associations Between Adiposity and Colorectal Cancer Risk by Inflammatory and Metabolic Biomarkers.
    Int J Cancer. 2018 Dec 6. doi: 10.1002/ijc.32047.
    PubMed     Text format     Abstract available


    Int J Colorectal Dis

  17. MCSORLEY ST, Johnstone M, Steele CW, Roxburgh CSD, et al
    Normocytic anaemia is associated with systemic inflammation and poorer survival in patients with colorectal cancer treated with curative intent.
    Int J Colorectal Dis. 2018 Dec 4. pii: 10.1007/s00384-018-3211.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  18. MILLER EA, Pinsky PF, Schoen RE, Prorok PC, et al
    Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial.
    Lancet Gastroenterol Hepatol. 2018 Nov 28. pii: S2468-1253(18)30358.
    PubMed     Text format     Abstract available


    Lancet Oncol

  19. DIENSTMANN R, Ciner A, Hochster HS
    Should next-generation sequencing testing be routinely used in metastatic colorectal cancer?
    Lancet Oncol. 2018;19:1434-1435.
    PubMed     Text format    


    PLoS One

  20. JODOIN R, Perreault JP
    G-quadruplexes formation in the 5'UTRs of mRNAs associated with colorectal cancer pathways.
    PLoS One. 2018;13:e0208363.
    PubMed     Text format     Abstract available

  21. GUO G, Chen X, He W, Wang H, et al
    Establishment of inflammation biomarkers-based nomograms to predict prognosis of advanced colorectal cancer patients based on real world data.
    PLoS One. 2018;13:e0208547.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: